Stephen Kilmer | Investor Relations |
Daniel White | Chief Executive Officer |
Glen Noronha | Chief Scientific Officer |
Charlie Deignan | Chief Financial Officer |
Annabel Samimy | Stifel |
Liana Moussatos | Wedbush |
Serge Belanger | Needham |
Donald Ellis | JMP Securities |
Good day, ladies and gentlemen and welcome to the Clearside Biomedical’s Fourth Quarter and Full-Year 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be provided at that time. [Operator Instructions] I’d now like to turn the conference over to Stephen Kilmer with Investor Relations. Please go ahead.